Earnings History Data for Dianthus Therapeutics, Inc. (DNTH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Dianthus Therapeutics, Inc.

Dianthus Therapeutics Inc. is a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics. Dianthus Therapeutics Inc., formerly known as Magenta Therapeutics Inc., is based in CAMBRIDGE, Mass.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-11-2024 PM DNTH Dianthus Therapeutics, Inc. 844.00 -0.74 -0.59 0.00 Dianthus Therapeutics GAAP EPS of -$0.74, revenue of $2.17M
[11/8/2024 12:28 AM]
28.59 -1.31 
(-4.38%)
29.71 -0.19 
(-0.64%)
6.58 - 33.77 130,004 130,000 30,668
08-08-2024 PM DNTH Dianthus Therapeutics, Inc. 828.54 -0.51 -0.50 -0.80 Dianthus Therapeutics GAAP EPS of -$0.51 beats by $0.04
[8/9/2024 3:27 AM]
27.66 0.92 
(3.44%)
26.74 0.0 
(0.00%)
6.58 - 33.77 119,504 270,000 3,461
09-05-2024 AH DNTH Dianthus Therapeutics, Inc. 706.00 -0.54 -0.43 0.00 Dianthus Therapeutics GAAP EPS of -$0.54 misses by $0.10, revenue of $0.87M beats by $0.5M
[5/9/2024 6:06 PM]
24.52 -0.41 
(-1.62%)
24.93 0.0 
(0.00%)
6.58 - 33.77 86,314 120,000 1,157